Will Genes Ruling Prevent the Next Genentech?

June 20 (Bloomberg) -- By ruling last week to restrict the ability of companies to own human genetic sequences, the Supreme Court may have also called into question thousands of biotechnology, agricultural and drug patents.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.